EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

The Differences in Clinical Outcomes for Unresectable Huge (≥ 10 cm) Hepatocellular Carcinoma With Portal Vein Thrombosis Treated by Two Different Radiotherapy Techniques

ZengLiang Huang, ZhongHua Chen, JuanJuan Shen, JianHai Lin, ShiLong Den, NanBao Zhong

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71926 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Medicine, online erschienen am 12.05.2026. Verfasst von ZengLiang Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Ward of the Radiology Department, 900th Hospital of PLA, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Portal Vein, Venous Thrombosis. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To explore a safe and effective treatment modality for unresectable huge (≥ 10 cm) hepatocellular carcinoma with portal vein thrombosis. And to provide more data on the synergistic antitumor effects of radiotherapy combined with immune checkpoint inhibitors and antiangiogenic therapy. Materials and Methods This study compared the clinical outcomes in 63 patients with unresectable huge hepatocellular carcinoma and portal vein thrombosis who were treated with either γ‐ray body radiotherapy or linear accelerator radiotherapy (the RTγ and RTa groups, respectively), both combined with immune checkpoint inhibitors and antiangiogenic therapy.

Results

The median progress‐free survival (PFS) and median overall survival (OS) in the RTγ group were 12.1 and 14.3 months, respectively. And those in the RTa group were 6.6 and 8.1 months, respectively. The 1‐, 2‐, and 3‐year PFS were 43.2%, 24.3%, 10.8% in the RTγ group and 11.5%, 3.8%, 0% in the RTa group, respectively. The OS at the same intervals were 56.7%, 40.5%, and 18.9% in the RTγ group, and those were 23.1%, 7.7%, and 0% in the RTa group, respectively. The percentage of normal liver volume (NLV) in whole liver volume (WLV) > 60% and negative viral infection are significant independent factors for superior PFS and OS. Severe radiation‐induced liver disease was observed in 23.1% ( n = 6) of patients in the RTa group, compared to none in the RTγ group.

Conclusions

RTγ combined with immune checkpoint inhibitors and antiangiogenic therapy is an effective and safe treatment modality for unresectable huge hepatocellular carcinoma with portal vein thrombosis. An NLV/WLV ratio > 60% and negative viral infection independently predicted better PFS and OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPortal VeinVenous ThrombosisHumansFemaleMaleMiddle AgedAgedTreatment OutcomeAdultRetrospective StudiesImmune Checkpoint InhibitorsAngiogenesis InhibitorsCombined Modality Therapy

Stichwörter der Autor:innen

clinical outcomehepatocellular carcinomaportal vein thrombosisradiotherapyγ‐Ray

Substanzen

Immune Checkpoint InhibitorsAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Interventional Ward of the Radiology Department, 900th Hospital of PLA, Fuzhou, China.
  • Department of Tumor Radiotherapy, 900th Hospital of PLA, Fuzhou, China.

Zitieren

APA

Huang, Z., Chen, Z., Shen, J., Lin, J., Den, S., & Zhong, N. (2026). The Differences in Clinical Outcomes for Unresectable Huge (≥ 10 cm) Hepatocellular Carcinoma With Portal Vein Thrombosis Treated by Two Different Radiotherapy Techniques. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71926

Vancouver

Huang Z, Chen Z, Shen J, Lin J, Den S, Zhong N. The Differences in Clinical Outcomes for Unresectable Huge (≥ 10 cm) Hepatocellular Carcinoma With Portal Vein Thrombosis Treated by Two Different Radiotherapy Techniques. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71926

BibTeX
@article{Huang2026,
  author = {Huang, ZengLiang and Chen, ZhongHua and Shen, JuanJuan and Lin, JianHai and Den, ShiLong and Zhong, NanBao},
  title = {The Differences in Clinical Outcomes for Unresectable Huge (≥ 10 cm) Hepatocellular Carcinoma With Portal Vein Thrombosis Treated by Two Different Radiotherapy Techniques},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71926}
}
Kostenlos starten →